Triton X-100-Modified Adenosine Triphosphate-Responsive siRNA Delivery Agent for Antitumor Therapy

Triton X-100-Modified Adenosine Triphosphate-Responsive siRNA Delivery Agent for Antitumor Therapy
复制标题

用于抗肿瘤治疗的 Triton X-100 修饰三磷酸腺苷响应 siRNA 递送剂

DOI:
10.1021/acs.molpharmaceut.0c00291
复制
发表时间:
2020-10-05
影响因子:
4.9
通讯作者:
Tang, Xinjing
Tang, Xinjing
中科院分区:
医学2区
文献类型:
--
作者:
Fan, Xinli;Zhao, Xiaoran;Tang, Xinjing

文献摘要

被引文献

相似文献

改性聚乙烯亚胺(PEI)已广泛用作 siRNA 递送剂。在此,我们开发了一种新的 Triton X-100 修饰的低分子量 PEI siRNA 递送剂,并结合 4-羧基苯基硼酸 (PBA) 和多巴胺接枝维生素 E (VEDA) 的偶联。 Triton X-100 是一种非离子去污剂,由于其高跨膜能力,极大地提高了 siRNA 的细胞摄取以及 siRNA 从内体/溶酶体的逃逸。此外,由于癌细胞中三磷酸腺苷(ATP)水平较高,转染剂的PBA和VEDA之间的硼酸键可以被触发释放其捕获的siRNA。该转染剂成功地将靶向表皮生长因子受体(EGFR)和驱动蛋白5(Eg5)内源基因的siRNA递送至癌细胞,在Eg5和EGFR沉默能力和抑制癌细胞迁移方面显示出良好的效果。进一步的体内研究表明,Triton X-100 修饰的转染剂也能有效地将 siRNA 递送至癌细胞,并对小鼠肿瘤模型显示出显着的肿瘤生长抑制作用。这些结果表明 Triton X-100 修饰的 ATP 响应转染剂是一种有前途的基因递送载体,用于体外和体内靶基因沉默。
Modified polyethyleneimine (PEI) has been widely used as siRNA delivery agents. Here, a new Triton X-100-modified low-molecular-weight PEI siRNA delivery agent is developed together with the coupling of 4-carboxyphenylboronic acid (PBA) and dopamine grafted vitamin E (VEDA). Triton X-100, a nonionic detergent, greatly improves the cellular uptake of siRNA as well as the siRNA escape from endosome/lysosome because of its high transmembrane ability. In addition, the boronate bond between PBA and VEDA of the transfection agent can be triggered to release its entrapped siRNA because of the high level of adenosine triphosphate (ATP) in cancer cells. The transfection agent is successfully applied to deliver siRNAs targeting endogenous genes of epidermal growth factor receptor (EGFR) and kinesin-5 (Eg5) to cancer cells, showing good results on Eg5 and EGFR silencing ability and inhibition of cancer cell migration. Further in vivo study indicates that the Triton X-100-modified transfection agent is also efficient to deliver siRNA to cancer cells and shows significant tumor growth inhibition on mice tumor models. These results indicate that the Triton X-100-modified ATP-responsive transfection agent is a promising gene delivery vector for target gene silencing in vitro and in vivo.